- Home
- PRAX vs HGTY Comparison
PRAX vs HGTY Comparison
Compare PRAX & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- HGTY
- Stock Information
- Founded
- PRAX 2015
- HGTY 1984
- Country
- PRAX United States
- HGTY United States
- Employees
- PRAX N/A
- HGTY N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- HGTY Specialty Insurers
- Sector
- PRAX Health Care
- HGTY Finance
- Exchange
- PRAX Nasdaq
- HGTY Nasdaq
- Market Cap
- PRAX 950.8M
- HGTY 820.4M
- IPO Year
- PRAX 2020
- HGTY N/A
- Fundamental
- Price
- PRAX $59.22
- HGTY $10.75
- Analyst Decision
- PRAX Strong Buy
- HGTY Hold
- Analyst Count
- PRAX 10
- HGTY 3
- Target Price
- PRAX $101.00
- HGTY $10.50
- AVG Volume (30 Days)
- PRAX 399.5K
- HGTY 90.5K
- Earning Date
- PRAX 08-12-2025
- HGTY 08-04-2025
- Dividend Yield
- PRAX N/A
- HGTY N/A
- EPS Growth
- PRAX N/A
- HGTY 124.60
- EPS
- PRAX N/A
- HGTY 0.20
- Revenue
- PRAX $8,122,000.00
- HGTY $1,247,923,000.00
- Revenue This Year
- PRAX N/A
- HGTY $15.41
- Revenue Next Year
- PRAX $4,434.72
- HGTY $15.88
- P/E Ratio
- PRAX N/A
- HGTY $52.90
- Revenue Growth
- PRAX 270.02
- HGTY 18.45
- 52 Week Low
- PRAX $26.70
- HGTY $8.03
- 52 Week High
- PRAX $91.83
- HGTY $12.35
- Technical
- Relative Strength Index (RSI)
- PRAX 78.36
- HGTY 78.22
- Support Level
- PRAX $53.89
- HGTY $10.08
- Resistance Level
- PRAX $59.10
- HGTY $10.15
- Average True Range (ATR)
- PRAX 3.26
- HGTY 0.20
- MACD
- PRAX 0.59
- HGTY 0.05
- Stochastic Oscillator
- PRAX 88.19
- HGTY 87.38
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.